Ran Karmi

Dr. Ran Karmi is a member of the firm’s Antitrust and Competition Department.

Ran advises both Israeli and foreign corporations on mergers and acquisitions, dominant and monopolistic status, restrictive arrangements, and tender agreements.

Ran represents the firm’s clients before the Israel Competition Authority, the Competition Tribunal, and all levels of Israeli courts in proceedings involving antitrust and competition matters, as well as in other commercial litigation.

He boasts extensive previous experience as an attorney specializing in intellectual property and its regulation.

Ran served as an antitrust research assistant to Professor Michal S. Gal and an intellectual property research assistant to Professor Niva Elkin-Koren, both at the University of Haifa. During the course of his studies at the University of Haifa, Ran served as chief counsel of the Student Union and took part in numerous and diverse academic projects.

Ran was awarded a Ph.D. in Law from Bar-Ilan University in 2025, with a dissertation on enhanced damages in contract law.

Prominent legal directory The Legal 500 ranks Ran as a Recommended Lawyer in Competition and Antitrust.

Prior to joining Barnea, Ran served in the antitrust and competition department of a boutique law firm.

Education:

University of Haifa, LL.M., Law and Technology Program (2nd in his class), 2011

University of Haifa, LL.B. (magna cum laude and Dean's List), 2011

University of Haifa, B.A. in Economics, 2011

Bar-Ilan University, Ph.D. in Law (Dissertation on Enhanced Damages in Contract Law), 2025

Admission:

Israel Bar Association, 2012

Insights & News - Ran Karmi:

January 1, 2026

2025 Year-End Review: Competition and Antitrust

The trends recorded in 2025 show that regulatory authorities are tightening enforcement, not only in cases of coordination between competitors, but also in cases involving public statements that may spur such coordination, non-controlling minority shareholding in competitors, or any other conduct that may raise barriers to competition.

See full article >

December 31, 2025

Expected Amendment to Israel’s Food Law: Significant Regulatory Relief for Small and Mid-Sized Pharma Chains

Legislative amendment focusing specifically on the pharma market: the Knesset is expected to approve an amendment to the Food Law, which seeks to adapt the unique regulations governing the pharma market to the competitive characteristics of the industry.

The New York Times v. Perplexity AI: New Frontiers in IP and AI

The New York Times recently filed a major lawsuit against the artificial intelligence platform Perplexity AI for infringement of intellectual property rights. The importance of this lawsuit lies in the fact that it does not rely solely on “classic” claims of copyright infringement, but also includes innovative claims of trademark violations and damages.

See all news updates from Ran Karmi >

Practice areas:

Antitrust and Competition